Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Classification of P-glycoprotein-substrates using similarity based descriptors

Rita Schwaha , Michael Demel , Dominik Kaiser , Gerhard Ecker
Jahrestagung 2007 der Deutschen Pharmazeutischen Gesellschaft (DPhG)
Conference, Poster presentation
..2007 - ..2007

NCI60 screening data - a versatile tool for in silico models predicting substrate properties for ABC-transporter

Barbara Zdrazil , Gerhard Ecker
234th ACS National Meeting
Conference, Poster presentation
..2007 - ..2007

Von Penicillin bis Viagra : Arzneistoffentwicklung gestern - heute - morgen

Gerhard Ecker
Talk or oral contribution
23.11.2006 - 23.11.2006

Von Penicillin bis Viagra : Arzneistoffentwicklung gestern - heute - morgen

Gerhard Ecker
Talk or oral contribution
22.11.2006 - 22.11.2006

In silico methods for hit identification and prediction of biological activities

Gerhard Ecker
Talk or oral contribution
16.11.2006 - 16.11.2006